Gut bacteria may hold the key to constipation relief
NCT ID NCT06637397
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This trial tests whether a daily probiotic called Weizmannia coagulans BC99 can relieve chronic constipation in adults. One hundred participants will receive either the probiotic or a placebo for several weeks. Researchers will measure changes in stool consistency, gut bacteria, and markers of inflammation to see if the probiotic improves symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a probiotic supplement called Weizmannia coagulans BC99
- What this could lead to
- If it works, this could offer a natural, side-effect-friendly option for managing chronic constipation without laxatives.
- What could go wrong
- This is a small, early-stage trial in Chinese adults only, so results may not apply to other groups. Probiotics affect people differently, and the benefit may be modest or no better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Oct 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Chinese adults who met the Rome III diagnostic criteria and were aged ≥20 years; 2. patients with chronic constipation (duration of more than 6 months, with less than 3 bowel movements per week and/or Bristol Scale Type 1 and 2); 3. patients in whom loose stools were rare without the use of laxatives; 4. The criteria for irritable bowel syndrome were insufficient; 5. patients that could complete the study according to the requirements of the trial protocol; 6. patients that had signed the informed consent form; 7. the study participants (including male subjects) had no fertility plans within 14 days before screening, and would voluntarily take effective contraceptive measures within 6 months after the end of the trial. Only those who met all of the above conditions could be selected. \- Exclusion Criteria: (1) Those who took items with similar functions to the test subjects in the short term, which may have affected their judgment of the results; (2) those who regularly used drugs that affect bowel habits; (3) patients who changed their diet during the study (such as regularly using a high-fiber diet, according to the recommended food score (RFS)); (4) those who were allergic to probiotics or the ingredients used in this study, those with severe immunodeficiency, or those with serious psychological or psychiatric diseases; (5) women who were pregnant, breastfeeding, or planning to become pregnant; (6) those who suffered from diseases that may cause secondary constipation, such as diabetes, thyroid disease, Alzheimer's disease, severe metabolic diseases, malignant tumors, and severe lesions of important organs (cardiovascular, lung, liver, kidney, etc.); (7) those who had used antibiotics in the two weeks prior; (8) those who did not consume the test samples as required, or were not followed up on time, resulting in uncertainty of efficacy; (9) those who had participated in another clinical trial within one month before enrollment; (10) subjects who were judged by other researchers to be unsuitable for participation. Those who met any of the above conditions were not selected. \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Constipation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Henan University of Science and Technology
Luoyang, Henan, 471000, China
-
The School of Food and Bioengineering, Henan University of Science and Technolog
Luoyang, Henan, 471000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercise boost the power of abdominal massage for constipation?
- Can a sticky pad on the belly replace invasive colon tests for kids?
- Could a breath test reveal Parkinson's risk?
- Could a simple fibre supplement reshape your gut microbiome?
- Unlocking the secrets of constipation: better tests on the horizon?
- Can light therapy unblock a common cancer side effect?